CAS 728033-96-3
:OSI-930
Description:
OSI-930, with the CAS number 728033-96-3, is a small molecule that functions primarily as a selective inhibitor of certain receptor tyrosine kinases, particularly those involved in cancer signaling pathways. It has been studied for its potential therapeutic applications in oncology, particularly in targeting tumors that exhibit aberrant signaling through these kinases. The compound is characterized by its ability to interfere with cellular proliferation and survival mechanisms, making it a candidate for cancer treatment. OSI-930 is typically administered in a clinical setting, and its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile. As with many investigational drugs, ongoing research aims to elucidate its full range of biological effects, optimal dosing regimens, and potential side effects. The development of OSI-930 reflects the broader trend in cancer therapy towards targeted treatments that minimize damage to healthy tissues while effectively combating malignant cells.
Formula:C22H16F3N3O2S
Synonyms:- 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide
- OSI 930
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
3-((Quinolin-4-Ylmethyl)Amino)-N-(4-(Trifluoromethoxy)Phenyl)Thiophene-2-Carboxamide
CAS:3-((Quinolin-4-Ylmethyl)Amino)-N-(4-(Trifluoromethoxy)Phenyl)Thiophene-2-CarboxamidePurity:99%Molecular weight:443.44g/molOSI-930
CAS:<p>OSI-930 is an oral c-Kit/VEGFR-2 inhibitor targeting tumor growth and angiogenesis.</p>Formula:C22H16F3N3O2SPurity:99.67%Color and Shape:SolidMolecular weight:443.44
